Morningstar (NASDAQ:MORN) Chairman Joseph Mansueto Sells 7,250 Shares of Stock

Morningstar, Inc. (NASDAQ:MORN) Chairman Joseph Mansueto sold 7,250 shares of the firm’s stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $175.96, for a total transaction of $1,275,710.00. Following the completion of the sale, the chairman directly owned 8,095,990 shares of the company’s stock, valued at approximately $1,424,570,400.40. This represents a 0.09% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Morningstar Price Performance

MORN opened at $175.82 on Wednesday. The company has a fifty day moving average price of $177.18 and a two-hundred day moving average price of $194.35. The company has a debt-to-equity ratio of 1.66, a quick ratio of 1.03 and a current ratio of 1.03. Morningstar, Inc. has a 52 week low of $149.08 and a 52 week high of $316.71. The firm has a market capitalization of $6.69 billion, a PE ratio of 17.90 and a beta of 0.99.

Morningstar (NASDAQ:MORN) last released its earnings results on Wednesday, April 29th. The business services provider reported $3.18 EPS for the quarter, topping analysts’ consensus estimates of $2.41 by $0.77. Morningstar had a net margin of 16.06% and a return on equity of 33.14%. The firm had revenue of $644.80 million during the quarter, compared to analyst estimates of $626.91 million.

Trending Headlines about Morningstar

Here are the key news stories impacting Morningstar this week:

• Negative Sentiment: Chairman Joseph D. Mansueto sold 4,002 shares at an average price of $177.08, trimming his ownership slightly in a transaction executed under a Rule 10b5-1 plan. SEC filing
• Negative Sentiment: He also sold 7,250 additional shares at an average price of $175.96, further reducing his stake modestly, which may be viewed as a bearish signal by some investors despite the planned nature of the sale. SEC filing
• Neutral Sentiment: Morningstar’s own editorial coverage highlighted themes such as fiscal risks, dividend investing, and AI-related opportunities, but these articles are informational and not direct company catalysts. Article
• Neutral Sentiment: The company also published “25 New 4-Star Stocks This Week,” which supports Morningstar’s core research brand but is unlikely to move the stock by itself. Article
• Positive Sentiment: Articles citing Morningstar data noted strong investor demand for dividend strategies and highlighted Morningstar research showing cheaper funds can outperform, reinforcing the value of the company’s analytics franchise. Article

Wall Street Analysts Forecast Growth

Several research firms recently commented on MORN. UBS Group set a $280.00 price objective on shares of Morningstar in a research report on Friday, February 13th. BMO Capital Markets cut their price target on shares of Morningstar from $257.00 to $193.00 and set an “outperform” rating on the stock in a research report on Tuesday, February 17th. Wall Street Zen upgraded shares of Morningstar from a “hold” rating to a “buy” rating in a research note on Saturday, May 2nd. Finally, Weiss Ratings lowered shares of Morningstar from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Thursday, April 9th. Two research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $236.50.

Institutional Trading of Morningstar

A number of institutional investors have recently bought and sold shares of MORN. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in Morningstar by 23.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 178 shares of the business services provider’s stock valued at $53,000 after purchasing an additional 34 shares during the period. Focus Partners Wealth boosted its holdings in Morningstar by 3.4% in the 1st quarter. Focus Partners Wealth now owns 3,838 shares of the business services provider’s stock valued at $1,151,000 after purchasing an additional 126 shares during the period. Geneos Wealth Management Inc. boosted its holdings in Morningstar by 278.2% in the 1st quarter. Geneos Wealth Management Inc. now owns 208 shares of the business services provider’s stock valued at $62,000 after purchasing an additional 153 shares during the period. EverSource Wealth Advisors LLC boosted its holdings in Morningstar by 2,450.0% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 561 shares of the business services provider’s stock valued at $176,000 after purchasing an additional 539 shares during the period. Finally, Qube Research & Technologies Ltd boosted its holdings in Morningstar by 58.8% in the 2nd quarter. Qube Research & Technologies Ltd now owns 138,932 shares of the business services provider’s stock valued at $43,615,000 after purchasing an additional 51,449 shares during the period. Institutional investors own 57.02% of the company’s stock.

About Morningstar

Morningstar, Inc is a leading provider of independent investment research, data, and analytics, serving both individual investors and financial professionals. The company offers comprehensive coverage of financial products, including mutual funds, exchange-traded funds (ETFs), stocks, bonds and market indexes. Morningstar’s proprietary rating systems and research methodologies help clients assess the risk and return profiles of investment opportunities and make informed decisions.

Its core products include Morningstar Direct, an institutional investment analysis platform; Morningstar Office Cloud, a portfolio management solution for advisors; and Morningstar Data, which delivers extensive datasets through APIs and data feeds.